Can the letter be e-signed?

Yes. Electronic signatures are generally valid under the federal ESIGN Act (15 U.S.C. §7001) and state UETA statutes where adopted, provided intent, consent, attribution, and reliable record retention are met.

Is notarization required?

Not typically for most investor representations, but state or transaction-specific requirements may demand notarization or witness signatures; verify local rules and closing agent instructions.

What if an investor changes information?

Amendments should be documented in a signed addendum or replacement letter. Clearly state the effective date and have both parties sign to avoid disputes.

How to revoke or cancel the letter?

Revocation should follow the terms of the subscription agreement. Typically, notify the issuer in writing and provide a signed revocation; rights to revoke may be limited after funding.

How long must copies be kept?

Retain executed letters per applicable retention rules: IRS records 3 years (IRC §6501(a)), HIPAA six years for health records (45 CFR §164.530(j)), and longer if industry rules require it.

What happens if a representation is false?

False statements can lead to contract rescission, indemnity claims, regulatory enforcement, or fraud liability; remedy language is commonly included in subscription agreements.

Electronic Signature
Templates
Legal
Investor Representation Letter

Investor Representation Letter

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

INVESTOR REPRESENTATION LETTER

This Investor Representation Letter (the "Letter") is delivered as of by Investor Name: (the "Investor") to Company Name: in connection with the offer and sale by the Company of certain securities (the "Securities").

RECITALS

WHEREAS, the Company proposes to sell Securities to certain purchasers, including the Investor, pursuant to a private placement transaction;

WHEREAS, the Company requires that each purchaser deliver written representations and warranties as a condition to such sale; and

WHEREAS, the Investor is willing to provide the representations and warranties contained in this Letter to induce the Company and its agents to effect such sale.

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the Investor hereby represents and warrants to the Company as follows:

1. REPRESENTATIONS AND WARRANTIES OF INVESTOR

1.1 Authority and Organization. If the Investor is an entity, it has full power and authority to execute and deliver this Letter and to perform its obligations hereunder. The Investor's organizational form is indicated below:

Individual Corporation Partnership Trust Other:

1.2 Investment Purpose. The Investor is acquiring the Securities for investment for its own account and not with a view to distribution, resale or public offering of the Securities. The Investor understands that transfer of the Securities is restricted and will be subject to legend and any required consents.

1.3 Accredited/Sophisticated Status. The Investor represents that it meets at least one of the following qualifications (check all that apply and provide amounts where required):

Has a net worth (alone or with spouse) in excess of $

Has annual income in excess of $ for each of the two most recent years and expects similar income for the current year.

Is an entity qualified by reason of organizational status or sophistication to participate in the offering.

The Investor agrees that it will promptly provide documentary evidence supporting the foregoing upon the Company's reasonable request.

1.4 Experience and Financial Ability. The Investor has such knowledge, sophistication and experience in financial and business matters that it is capable of evaluating the merits and risks of the investment and can bear the economic risk of loss of the entire investment.

1.5 No General Solicitation. The Investor's attention was not obtained as a result of any form of general solicitation or general advertising.

1.6 Compliance with Laws. The execution, delivery and performance of this Letter by the Investor and the consummation by the Investor of the transactions contemplated herein will not violate any agreement, law, judgment or order applicable to the Investor.

1.7 Tax and Residency Information. The Investor's principal residence or principal place of business is:

Investor Address

2. ACKNOWLEDGMENT OF RISKS

The Investor acknowledges that the purchase of the Securities involves a high degree of risk, including the potential loss of the entire investment, illiquidity, lack of current market and dilution. The Investor has reviewed and understands the risks disclosed by the Company and confirms that it is able to bear such risks.

3. INFORMATION AND NON-RELIANCE

The Investor confirms it has received access to such information regarding the Company and the Securities as it reasonably deems necessary to evaluate the investment and has had the opportunity to ask questions and receive answers from the Company's representatives. The Investor acknowledges that no person has made any representation or warranty to it except as expressly set forth in any definitive agreement between the parties.

4. TRANSFER RESTRICTIONS

The Investor understands that the Securities have not been registered under applicable securities laws and may not be sold, pledged, assigned or otherwise transferred unless: (a) such transfer is made pursuant to an effective registration statement or an exemption from registration; and (b) the Company receives an opinion of counsel satisfactory to the Company (or such other evidence as the Company may reasonably require) to the effect that such transfer is lawful. The Securities may bear a restrictive legend and other transfer conditions.

5. COMPLIANCE, SANCTIONS AND AML

The Investor represents that neither it nor any beneficial owner of the Securities is a person or entity subject to sanctions, blocked or designated by any governmental authority, and the funds used to purchase the Securities are not derived from illegal activities. The Investor agrees to provide additional information or documentation to satisfy anti-money laundering and sanctions checks if reasonably requested.

6. INDEMNIFICATION

The Investor agrees to indemnify and hold harmless the Company, its officers, directors and agents from and against any loss, liability or expense arising out of or based upon any breach of any representation, warranty or covenant made by the Investor in this Letter.

7. CONFIDENTIALITY

The Investor will keep confidential all non-public information provided by the Company in connection with the offering, except where disclosure is required by law or judicial process. The Investor will not use such information for any purpose other than evaluating and consummating the purchase of the Securities.

8. NOTICES

Any notices or communications required or permitted hereunder shall be in writing and delivered to the addresses set forth below (or such other address as a party may designate by notice).

Company Notices Address Investor Notices Address

9. AMENDMENTS AND WAIVER

This Letter may be amended, modified or waived only by a written instrument executed by the party against whom enforcement of such amendment, modification or waiver is sought.

10. GOVERNING LAW

This Letter shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles.

11. ENTIRE AGREEMENT; SEVERABILITY

This Letter, together with any purchase agreement relating to the Securities, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, whether written or oral. If any provision of this Letter is held invalid or unenforceable, such invalidity or unenforceability shall not affect the remaining provisions, which shall remain in full force and effect.

12. COUNTERPARTS

This Letter may be executed in counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument. Facsimile or electronic signatures shall be effective as originals for all purposes.

ADDITIONAL INFORMATION

Source of Funds / Additional Representations (if required)

Investor:

By:

Date:

Company:

By:

Date:

What an Investor Representation Letter Is

An Investor Representation Letter is a written statement by an investor confirming facts and commitments relevant to an investment transaction, such as accreditation status, source of funds, and absence of conflicting obligations. It typically accompanies subscription agreements, private placement memoranda, or closing documents and helps issuers assess regulatory and contractual eligibility before accepting funds.

Why this letter matters in transactions

The letter allocates risk, documents factual assertions, and supports issuer compliance with securities law and internal due diligence. Properly completed investor representations reduce fraud risk, speed closing, and create a clear record that can be relied on in audits or regulatory reviews under ESIGN and state electronic transaction laws.

Typical users and stakeholders

The Investor Representation Letter is completed by investors and reviewed by issuer counsel, compliance officers, and transaction teams before funding.

Startup founders and private companies that accept investment need documented investor assertions for capital raises and recordkeeping.
Accredited and institutional investors provide the letter to certify status, source of funds, and suitability for private placements.
Corporate and securities counsel review, negotiate representations, and maintain copies for regulatory and audit purposes.

Clear roles reduce rework: identify who completes fields, who reviews legal clauses, and who manages filing and retention.

Essential parts of a professional Investor Representation Letter

A complete letter is structured to make each representation explicit, identify parties, state dates, and provide signature and authentication details to ensure enforceability.

Representations

Clear, itemized factual statements about investor status, authority, compliance with laws, and absence of conflicts; each item should be specific and unambiguous.

Warranties

Short assurances that certain facts are true as of the date of signing, often overlapping with representations but framed as promises subject to remedies.

Conditions

Any closing conditions tied to the representations, such as required documents, verification steps, or escrow instructions that must be satisfied before funding.

Consideration

A description of the investment amount, payment method, and allocation of units or shares, including wire instructions if funds are transferred at closing.

Disclosure Schedules

Attachments or schedules listing exceptions, supporting evidence, or disclosures that qualify or explain any representation to avoid ambiguity.

Signature Block

Designated signature, printed name, title, date, and any witness or notarization lines required for enforceability or investor verification.

Filling and delivering the letter: step-by-step

Follow a simple sequence: gather supporting documents, complete the form, obtain required reviews, and finalize signatures and distribution.

01

Gather Documents: Collect ID, formation documents, proof of funds, and accreditation evidence before starting.
02

Complete Fields: Enter legal names, addresses, amounts, and representations exactly as instructed.
03

Legal Review: Have issuer or investor counsel review representations and any attached schedules.
04

Sign and Send: Execute signatures, notarize if required, then distribute to all parties and retain copies.

Typical electronic workflow for completion and delivery

An eSigning workflow reduces paper handling and creates a time-stamped audit trail; ensure authentication and consent are configured in advance.

Upload Document: Sender uploads the finalized letter template into the signing platform.
Place Fields: Add signature, date, and optional checkboxes or initials for each signer.
Invite Signers: Send secure signing links or email invitations with authentication controls.
Archive Record: Signed copies and audit trails are stored for retention and compliance purposes.

Recommended online configuration settings

Configure the signing workflow to match transaction risk tolerance and verification needs before sending investor letters for signature.

Field	Configuration
Signature Order	Sequential or parallel, set by role and closing process
Authentication Level	Email link standard; SMS code or KBA for higher assurance
Conditional Fields	Show additional disclosures only when specific responses are selected
Audit Trail Retention	Retain signed PDF and event log for required retention period

Digital signing and technical needs

Use an eSignature platform that supports secure authentication, tamper-evident signed PDFs, and audit logs for legal defensibility.

Authentication: Email, SMS, or knowledge-based options
Integrations: Salesforce, NetSuite, Google Workspace supported
Formats: PDF, DOCX export with embedded audit trail

Common timing checkpoints and deadlines

Plan the letter's completion around the transaction calendar: negotiate terms, confirm representations, execute, and complete funding steps.

Negotiation Window:

Complete before final subscription agreement execution; typically 1–2 business days prior.

Execution Date:

Sign on or immediately before the closing date; use MM/DD/YYYY format for the effective date.

Funding Deadline:

Wire or transfer funds per closing instructions, usually within 24–48 hours of executed documents.

Post-Closing Filings:

Issuer files any required notices or updates per securities law timelines after closing.

Document Retention:

Store signed letters according to retention policy and applicable regulations.

Common preparation mistakes to avoid

Using informal or trade names instead of the investor's exact legal name, which can invalidate authority to bind an entity.
Failing to include or attach accreditation proof when the issuer explicitly requires supporting documentation under subscription terms.
Not specifying the exact investment amount or tranche schedule, leading to disputes over funding obligations and allocation.
Neglecting to obtain clear electronic consent to do business electronically where consumer-facing disclosures are required.

Risks and potential consequences of errors

Misstatements: Fraud exposure and rescission risk

Invalid Signature: May render the representation unenforceable

Regulatory Risk: SEC inquiries or enforcement actions

Tax Impact: Incorrect reporting and penalties

Contract Remedies: Damages, indemnities, or termination rights

Reputational Harm: Loss of investor or partner confidence

Security and compliance features to expect

Encryption: TLS 1.2/1.3 in transit, AES-256 at rest

Audit Trail: Comprehensive event logging and timestamps

Certifications: SOC 2 Type II and ISO 27001 certified

HIPAA: HIPAA-compliant with BAA available

21 CFR Part 11: Support for FDA-regulated records where required

Accessibility: WCAG 2.0 Level AA conformance

Pricing snapshot for eSignature platforms used with investor letters

Compare basic pricing and core capabilities across common providers to choose an eSignature option that fits transaction volume and compliance needs.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-world examples of investor letters in use

These examples show how organizations use investor representations to accelerate closings while maintaining compliance.

Optica Ventures LLC

Optica streamlined capital raises by standardizing investor attestations across transactions.

The team reduced back-and-forth by centralizing templates.
The interface simplicity improved both internal processing and customer completion times, making it easier to close rounds without repeated document exchanges.

Xerox (NetSuite)

Xerox automated investor attestations within integrated workflows for faster verification.

Integration with ERP sped reconciliation.
Flexibility to produce signatures in the correct formats and link records to NetSuite decreased manual entry and improved audit readiness.

Who typically signs and why

General Counsel

General counsel or outside securities counsel review representations to ensure legal sufficiency, negotiate language that allocates risk appropriately, and advise on necessary supporting documentation before recommending execution.

Investor Signatory

An authorized investor representative—an individual with signing authority or an officer of an entity—signs to attest to facts like accreditation, source of funds, and absence of conflicting obligations.

Frequently asked questions about Investor Representation Letters

Answers to common questions about validity, signatures, revisions, and recordkeeping to reduce execution delays and legal uncertainty.

Need help? Contact support

Can the letter be e-signed?
Yes. Electronic signatures are generally valid under the federal ESIGN Act (15 U.S.C. §7001) and state UETA statutes where adopted, provided intent, consent, attribution, and reliable record retention are met.
Is notarization required?
Not typically for most investor representations, but state or transaction-specific requirements may demand notarization or witness signatures; verify local rules and closing agent instructions.
What if an investor changes information?
Amendments should be documented in a signed addendum or replacement letter. Clearly state the effective date and have both parties sign to avoid disputes.
How to revoke or cancel the letter?
Revocation should follow the terms of the subscription agreement. Typically, notify the issuer in writing and provide a signed revocation; rights to revoke may be limited after funding.
How long must copies be kept?
Retain executed letters per applicable retention rules: IRS records 3 years (IRC §6501(a)), HIPAA six years for health records (45 CFR §164.530(j)), and longer if industry rules require it.
What happens if a representation is false?
False statements can lead to contract rescission, indemnity claims, regulatory enforcement, or fraud liability; remedy language is commonly included in subscription agreements.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now